This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Pavel Martásek, MD; Milan Jirsa, MD, DSc; Václav Korda, MD, DSc
Prague

Arch Dermatol. 1982;118(9):624-625.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

For some time, we have been studying porphyrins and, especially, their colorless precursors, porphyrinogens, in plasma. For their determination, we use direct spectrofluorometry. We call attention to the excellent results of Poh-Fitzpatrick, who described the differentiation of various types of porphyrias by the use of direct spectrofluorometry of diluted plasma in the May 1980

619 680 619 680 626 687 626 687

Fluorescence Emission Maximum, nm

Fig 1.—Fluorescence emission spectrum of plasma from patient with acute intermittent porphyria at left. Fluorescence emission spectrum 1 indicates amount of porphyrins present in oxidized form (without Lugol's solution as oxidation agent); 2 indicates total amount of porphyrins after oxidation of porphyrinogens to corresponding porphyrins. Fluorescence emission spectrum of plasma from patient with variegate porphyria at right. Fluorescence emission spectrum 1 indicates amount of porphyrins present in oxidized form (without Lugol's solution as oxidation agent); 2 indicates total amount of porphyrins . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?